Carl Magnus Högerkorp
Directeur Général chez CYXONE AB
Profil
Carl Magnus Högerkorp is the founder of Immodulate Pharma AB, which was founded in 2021.
He held the title of Chief Executive Officer at Immodulate Pharma AB.
He is currently the Chief Executive Officer & Director at Cyxone AB, starting in 2023.
Dr. Högerkorp's former positions include being the Chief Executive Officer at CanImGuide Therapeutics AB from 2019 to 2021, the Chief Executive Officer at Edvince AB from 2017 to 2018, and the Chief Science Officer at Xintela AB from 2016 to 2017.
Dr. Högerkorp has a doctorate degree from the University of Lund and an MBA from Lund University School of Economics & Management.
Postes actifs de Carl Magnus Högerkorp
| Sociétés | Poste | Début |
|---|---|---|
| CYXONE AB | Directeur Général | 20/06/2022 |
Anciens postes connus de Carl Magnus Högerkorp
| Sociétés | Poste | Fin |
|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Directeur Général | 01/04/2021 |
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Directeur Général | 01/10/2018 |
| XINTELA AB | Directeur Technique/Scientifique/R&D | 01/04/2017 |
| Immodulate Pharma AB | Directeur Général | - |
Formation de Carl Magnus Högerkorp
| University of Lund | Doctorate Degree |
| Lund University School of Economics & Management | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| XINTELA AB | Health Technology |
| CYXONE AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
Edvince AB
Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
| Immodulate Pharma AB |
